Agarwal Arjun sold ORKA
September 21, 2026 · Form 4 insider transaction
Agarwal Arjun sold 533 shares of Oruka Therapeutics, Inc. at $95.75 per share, a transaction worth $51.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
533
Price
$95.75
Total value
$51.0K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 21, 2026
Filing dateSeptember 21, 2026
Shares owned after14,219
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.